Cyrus Biotechnology
Latest round
- Series B
Last raised
- Feb 2024
Total raised
- $26M
Investors
- 12
About Cyrus Biotechnology
Founded in 2014 and based in Washington, US, Cyrus Biotechnology Inc. operates as a software company that offers a biologics discovery platform. The company was founded by David Baker. In December 2021, Cyrus Biotechnology Inc., and The Yard Ventures. Cyrus Biotechnology’s product line includes Cyrus Bench, which is a Rosetta-based protein design software that consists of a molecular modeling and design toolkit to solve protein engineering and structure prediction problems with the help of artificial intelligence; Cyrus API, which is a cloud-based platform for computational modeling and bioinformatics; deimmunization, a machine learning-based protein design platform for eliminating the immunogenicity of therapeutic proteins; and Cyrus’s protein biochemistry platform that uses deep mutational scanning and selection to explore the mutational landscape of proteins. The firm’s pipeline portfolio includes CRISPR (clustered, regularly interspaced short palindromic repeats), a bacterial enzyme system; ACE2, which is a protein-based therapeutic for COVID-19; and a treg-selective IL-2 protein agonist (IL-2).
Who invested in Cyrus Biotechnology
12 investors across 3 rounds
See all investors in Cyrus Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cyrus Biotechnology
Who invested in Cyrus Biotechnology?
Cyrus Biotechnology has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cyrus Biotechnology raised?
Cyrus Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cyrus Biotechnology last raise money?
Cyrus Biotechnology's most recent round on record is a Series B, in Feb 2024.
What does Cyrus Biotechnology do?
Founded in 2014 and based in Washington, US, Cyrus Biotechnology Inc.
Where is Cyrus Biotechnology headquartered?
Cyrus Biotechnology is headquartered in Seattle, US.
Which VCs invest in companies like Cyrus Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Cyrus Biotechnology's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Cyrus Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.